Company: KG
Filing Date: 2025-03-26
Form Type: 424B3
Source: 0001104659-25-028251
Chunk: 285

Company: Kestrel Group Ltd
Filing Date: 2025-03-26
Form: 424B3
Chunk 285
---
,117,237 | ​ | ​ |
| William T. Jarman  | ​ | ​ | ​          | ​ |         — | ​ | ​ | ​ | ​            | ​ |       — | ​ | ​ | ​ | ​                           | ​ |       — | ​ | ​ | ​ | ​           | ​ |       — | ​ | ​ | ​ | ​        | ​ |         — | ​ | ​ |
| Mark O. Heintzman  | ​ | ​ | ​          | ​ |         — | ​ | ​ | ​ | ​            | ​ |       — | ​ | ​ | ​ | ​                           | ​ |       — | ​ | ​ | ​ | ​           | ​ |       — | ​ | ​ | ​ | ​        | ​ |         — | ​ | ​ |

(1) The amounts in this column represent the continued payment of base salary until May 1, 2028, assuming the termination of employment of Mr. Haveron or Mr. Metz without cause under the terms of the employment agreements as of March 3, 2025. Although these amounts are payable irrespective of whether the employment termination is in connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement. (2) The amounts in this column represent the equity awards that will continue to vest until March 14, 2026, assuming the termination of employment of Mr. Haveron or Mr. Metz without cause under the terms of the restricted share award agreements dated as of March 17, 2023 and March 14, 2024. Although these amounts are payable irrespective of whether the employment termination is in connection with the mergers or a change in control, out of an abundance of caution we are describing them in this prospectus/proxy statement. The amounts in this column do not include equity awards that will continue to remain subject to performance vesting conditions assuming the termination of employment of Mr. Haveron or Mr. Metz without cause under the terms of the restricted share award agreements dated as of March 17, 2023 and March 7, 2024. (3) The amounts in this column represent the approximate value of continued payment of certain employee benefits including medical insurance ($47,424 and $47,424), executive life insurance ($22,766 and $2,263), supplemental allowance ($56,909 and $37,939) and executive physical